Kelly Jean Thomas Craig
International Olympic Committee(CH)Aetna (United States)(US)Wellesley College(US)VA Office of Research and Development(US)CVS Health (United States)(US)Crowell & Moring (United States)(US)Hartford Financial Services (United States)British Athletics(GB)
Publications by Year
Research Areas
Primary Care and Health Outcomes, Mitochondrial Function and Pathology, Healthcare Policy and Management, Patient Satisfaction in Healthcare, Parkinson's Disease Mechanisms and Treatments
Most-Cited Works
- → Kinase activity is required for the toxic effects of mutant LRRK2/dardarin(2006)744 cited
- → DJ-1 acts in parallel to the PINK1/parkin pathway to control mitochondrial function and autophagy(2010)447 cited
- → Mitochondrial function and morphology are impaired in parkin‐mutant fibroblasts(2008)345 cited
- → The Parkinson Disease-associated Leucine-rich Repeat Kinase 2 (LRRK2) Is a Dimer That Undergoes Intramolecular Autophosphorylation(2008)315 cited
- → Pink1 Forms a Multiprotein Complex with Miro and Milton, Linking Pink1 Function to Mitochondrial Trafficking(2009)288 cited
- → Formation of a Stabilized Cysteine Sulfinic Acid Is Critical for the Mitochondrial Function of the Parkinsonism Protein DJ-1(2009)275 cited